In a patient receiving capecitabine and temozolomide for well-differentiated neuroendocrine tumor, how long do you continue the temozolomide?
Do you drop or adjust the temozolomide at any point, or rather continue to progression as long as temozolomide is well tolerated?
Answer from: Medical Oncologist at Academic Institution
The true answer is that we do not know. There is no question the CAPTEM combo is effective and the highest quality data comes from ECOG E2211 which was just updated at this year's ASCO. In that trial, patients received up to 13 cycles. In the past, there was the temptation to continue CAPTEM as...
Sign in or Register to read more